Clinical Trial Update: Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate Cancer [Phase 1]

View source ↗

Summary

This Phase 1 study of lenalidomide in combination with docetaxel for androgen-independent prostate cancer has completed, evaluating safety, tolerability, and do…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Revlimid (lenalidomide)
• Taxotere (docetaxel)

Snippet

Sponsor: Columbia University | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED